Showing 4651-4660 of 8791 results for "".
Business Planning for Premium Services
https://crstoday.com/topics/general/crst1109_12-php/41530/A checklist for the introduction of new offerings.Expanding With a Plan
https://crstoday.com/topics/general/crst0707_12-php/41209/For Carl Zeiss Meditec, Inc., growth is contingent on value.Neural Adaptation to Aberrations
https://crstoday.com/topics/general/crst0807_13-php/41193/The brain must adjust to a surgically altered visual system.The Mindset of the Refractive Patient
https://crstoday.com/crst-issues/2005-mar/0305_f4_shareef-html/40854/Using what we have learned so far to improve how we attract consumers.Small Practice Expansion
https://crstoday.com/crst-issues/2003-mar/0303_281-html/40419/The first installment of a two-part series reviews the timing and strategies for introducing a new shareholder to a small practice.Small Practice Expansion
https://crstoday.com/crst-issues/2002-sep/0902_281-html/40123/The first installment of a two-part series reviews the timing and strategies for introducing a new shareholder to a small practice.The Limits of Combining Phacoemulsification and MIGS
https://crstoday.com/crst-issues/july-2026-issue/the-limits-of-combining-phacoemulsification-and-migs/61141/A glaucoma surgeon’s guide for cataract colleagues.Late Spontaneous Dislocation of the IOL–Capsular Bag Complex in a Patient With Retinitis Pigmentosa
https://crstoday.com/crst-issues/sept-2024/late-spontaneous-dislocation-of-the-iol-capsular-bag-complex-in-a-patient-with-retinitis-pigmentosa/45373/A comprehensive review of the diagnosis, surgical management, and outcomes of late spontaneous dislocation of the IOL–capsular bag complex in a 72-year-old patient with retinitis pigmentosa.Demodex Blepharitis
https://crstoday.com/crst-issues/sept-2024/demodex-blepharitis/45359/Long-term treatment and the condition’s relation to rosacea.Contact Lens Cessation Policy for Refractive Surgery
https://crstoday.com/topics/refractive-surgery/contact-lens-cessation-policy-for-refractive-surgery/44999/It is high time to reevaluate discontinuation protocols.